LEMAITRE VASCULAR, INC. (LMAT) Total liabilities 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) total liabilities at each fiscal year-end, per SEC filings.
$222.2MFY2025 · since FY2016: $14.4M → $222.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $222.2M | +3.6% |
| FY2024 | $214.5M | +338.9% |
| FY2023 | $48.9M | +15.6% |
| FY2022 | $42.3M | +9.4% |
| FY2021 | $38.7M | -51.8% |
| FY2020 | $80.2M | +99.6% |
| FY2019 | $40.2M | +75.9% |
| FY2018 | $22.9M | +38.1% |
| FY2017 | $16.6M | +14.8% |
| FY2016 | $14.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross profitLMAT Gross marginLMAT Operating incomeLMAT Operating marginLMAT Operating cash flowLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Shareholders’ equityLMAT overview →